|
Dec 31
|
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
|
|
Apr 7
|
Alcon Publishes Agenda for 2024 Annual General Meeting
|
|
Jan 9
|
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
|